Source of oncofetal ED-B-containing fibronectin: Implications of production by both tumor and endothelial cells

Citation
M. Midulla et al., Source of oncofetal ED-B-containing fibronectin: Implications of production by both tumor and endothelial cells, CANCER RES, 60(1), 2000, pp. 164-169
Citations number
31
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER RESEARCH
ISSN journal
00085472 → ACNP
Volume
60
Issue
1
Year of publication
2000
Pages
164 - 169
Database
ISI
SICI code
0008-5472(20000101)60:1<164:SOOEFI>2.0.ZU;2-A
Abstract
ED-B fibronectin (FN) is a FN isoform derived from alternative splicing of the primary transcript of a single gene, Its expression on tumor stroma and neoformed tumor vasculature and its absence, with few exceptions, in norma l adult tissues imply a prognostic and diagnostic value for ED-B FN, We inv estigated the location and source of ED-B FN because this will he of import ance both in understanding its role in tumor development and in designing s trategies to target this molecule. We have confirmed that ED-B FN is expres sed in the majority of breast and colorectal carcinoma tissue samples, with strong immunohistochemical staining around the tumor cells and in the tumo r stroma, No staining of tumor neovasculature was seen. ED-B FN is produced by a range of tumor and endothelial (both primary and transformed) cell li nes, as detected by reverse transcription-PCR, but is not expressed at the plasma membrane, Strong expression of human ED-B FN is seen in tumor xenogr afts, These data indicate that neoplastic cells can act as the source of ED -B FN in tumors. The lack of cell surface expression on tumor cell lines ha s clear implications for the design of therapeutic strategies which target this molecule.